Abstract
We present the case of a 20-year-old woman who developed rhabdomyolysis, disseminated intravascular coagulopathy and multi-organ failure induced by ecstasy. Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg.kg(-1) dantrolene. Subsequent genetic testing revealed a novel potentially pathogenic variant in the ryanodine receptor type 1 gene. However, caffeine-halothane contracture testing of the patient's mother who carried the same gene variant was negative for malignant hyperthermia.
Anaesthesia © 2012 The Association of Anaesthetists of Great Britain and Ireland.
MeSH terms
-
Anesthetics, Inhalation
-
Antipsychotic Agents / adverse effects
-
Body Temperature
-
Caffeine
-
Central Nervous System Stimulants
-
Chromatography, High Pressure Liquid
-
Creatine Kinase / blood
-
Dantrolene / therapeutic use
-
Disseminated Intravascular Coagulation / etiology
-
Female
-
Genetic Variation
-
Hallucinogens / adverse effects*
-
Haloperidol / adverse effects
-
Halothane
-
Humans
-
Multiple Organ Failure / chemically induced
-
Multiple Organ Failure / physiopathology
-
N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
-
Neuroleptic Malignant Syndrome / genetics*
-
Neuroleptic Malignant Syndrome / physiopathology*
-
Recurrence
-
Rhabdomyolysis / chemically induced*
-
Rhabdomyolysis / genetics
-
Rhabdomyolysis / physiopathology
-
Ryanodine Receptor Calcium Release Channel / genetics*
-
Spectrum Analysis
-
Young Adult
Substances
-
Anesthetics, Inhalation
-
Antipsychotic Agents
-
Central Nervous System Stimulants
-
Hallucinogens
-
Ryanodine Receptor Calcium Release Channel
-
Caffeine
-
Creatine Kinase
-
Dantrolene
-
Haloperidol
-
N-Methyl-3,4-methylenedioxyamphetamine
-
Halothane